Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality
Arsenic has been linked to increased prevalence of cancer and cardiovascular disease (CVD), but the long-term impact of arsenic exposure remains unclear. Human paraoxonase (PON1) is a high-density lipoprotein-associated antioxidant enzyme which hydrolyzes oxidized lipids and is thought to be protect...
Saved in:
Published in | Toxicology and applied pharmacology Vol. 239; no. 2; pp. 178 - 183 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article Conference Proceeding |
Language | English |
Published |
Amsterdam
Elsevier Inc
01.09.2009
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 0041-008X 1096-0333 1096-0333 |
DOI | 10.1016/j.taap.2008.12.017 |
Cover
Abstract | Arsenic has been linked to increased prevalence of cancer and cardiovascular disease (CVD), but the long-term impact of arsenic exposure remains unclear. Human paraoxonase (PON1) is a high-density lipoprotein-associated antioxidant enzyme which hydrolyzes oxidized lipids and is thought to be protective against atherosclerosis, but evidence remains limited to case-control studies. Only recently have genes encoding enzymes responsible for arsenic metabolism, such as AS3MT and GSTO, been cloned and characterized. This study was designed to evaluate the synergistic interaction of genetic factors and arsenic exposure on electrocardiogram abnormality. A total of 216 residents from three tap water implemented villages of previous arseniasis-hyperendemic regions in Taiwan were prospectively followed for an average of 8 years. For each resident, a 12-lead conventional electrocardiogram (ECG) was recorded and coded by Minnesota Code standard criteria. Eight functional polymorphisms of PON1, PON2, AS3MT, GSTO1, and GSTO2 were examined for genetic susceptibility to ECG abnormality. Among 42 incident cases with ECG deterioration identified among 121 baseline-normal subjects, arsenic exposure was significantly correlated with incidence of ECG abnormality. In addition, polymorphisms in two paraoxonase genes were also found associated with the incidence of ECG abnormality. A haplotype R-C-S constituted by polymorphisms of PON1 Q192R, -108C/T and PON2 C311S was linked to the increased risk. Subjects exposed to high levels of As (cumulative As exposure >14.7 ppm-year or drinking artesian well water >21 years) and carrying the R-C-S haplotype had significantly increased risks for ECG abnormality over those with only one risk factor. Results of this study showed a long-term arsenic effect on ECG abnormality and significant gene–gene and gene–environment interactions linked to the incidence of CVD. This finding might have important implications for a novel and potentially useful biomarker of arsenic risk. |
---|---|
AbstractList | Arsenic has been linked to increased prevalence of cancer and cardiovascular disease (CVD), but the long-term impact of arsenic exposure remains unclear. Human paraoxonase (PON1) is a high-density lipoprotein-associated antioxidant enzyme which hydrolyzes oxidized lipids and is thought to be protective against atherosclerosis, but evidence remains limited to case-control studies. Only recently have genes encoding enzymes responsible for arsenic metabolism, such as AS3MT and GSTO, been cloned and characterized. This study was designed to evaluate the synergistic interaction of genetic factors and arsenic exposure on electrocardiogram abnormality. A total of 216 residents from three tap water implemented villages of previous arseniasis-hyperendemic regions in Taiwan were prospectively followed for an average of 8 years. For each resident, a 12-lead conventional electrocardiogram (ECG) was recorded and coded by Minnesota Code standard criteria. Eight functional polymorphisms of PON1, PON2, AS3MT, GSTO1, and GSTO2 were examined for genetic susceptibility to ECG abnormality. Among 42 incident cases with ECG deterioration identified among 121 baseline-normal subjects, arsenic exposure was significantly correlated with incidence of ECG abnormality. In addition, polymorphisms in two paraoxonase genes were also found associated with the incidence of ECG abnormality. A haplotype R-C-S constituted by polymorphisms of PON1 Q192R, -108C/T and PON2 C311S was linked to the increased risk. Subjects exposed to high levels of As (cumulative As exposure >14.7 ppm-year or drinking artesian well water >21 years) and carrying the R-C-S haplotype had significantly increased risks for ECG abnormality over those with only one risk factor. Results of this study showed a long-term arsenic effect on ECG abnormality and significant gene-gene and gene-environment interactions linked to the incidence of CVD. This finding might have important implications for a novel and potentially useful biomarker of arsenic risk. Arsenic has been linked to increased prevalence of cancer and cardiovascular disease (CVD), but the long-term impact of arsenic exposure remains unclear. Human paraoxonase (PON1) is a high-density lipoprotein-associated antioxidant enzyme which hydrolyzes oxidized lipids and is thought to be protective against atherosclerosis, but evidence remains limited to case-control studies. Only recently have genes encoding enzymes responsible for arsenic metabolism, such as AS3MT and GSTO, been cloned and characterized. This study was designed to evaluate the synergistic interaction of genetic factors and arsenic exposure on electrocardiogram abnormality. A total of 216 residents from three tap water implemented villages of previous arseniasis-hyperendemic regions in Taiwan were prospectively followed for an average of 8 years. For each resident, a 12-lead conventional electrocardiogram (ECG) was recorded and coded by Minnesota Code standard criteria. Eight functional polymorphisms of PON1, PON2, AS3MT, GSTO1, and GSTO2 were examined for genetic susceptibility to ECG abnormality. Among 42 incident cases with ECG deterioration identified among 121 baseline-normal subjects, arsenic exposure was significantly correlated with incidence of ECG abnormality. In addition, polymorphisms in two paraoxonase genes were also found associated with the incidence of ECG abnormality. A haplotype R-C-S constituted by polymorphisms of PON1 Q192R, -108C/T and PON2 C311S was linked to the increased risk. Subjects exposed to high levels of As (cumulative As exposure >14.7 ppm-year or drinking artesian well water >21 years) and carrying the R-C-S haplotype had significantly increased risks for ECG abnormality over those with only one risk factor. Results of this study showed a long-term arsenic effect on ECG abnormality and significant gene–gene and gene–environment interactions linked to the incidence of CVD. This finding might have important implications for a novel and potentially useful biomarker of arsenic risk. Arsenic has been linked to increased prevalence of cancer and cardiovascular disease (CVD), but the long-term impact of arsenic exposure remains unclear. Human paraoxonase (PON1) is a high-density lipoprotein-associated antioxidant enzyme which hydrolyzes oxidized lipids and is thought to be protective against atherosclerosis, but evidence remains limited to case-control studies. Only recently have genes encoding enzymes responsible for arsenic metabolism, such as AS3MT and GSTO, been cloned and characterized. This study was designed to evaluate the synergistic interaction of genetic factors and arsenic exposure on electrocardiogram abnormality. A total of 216 residents from three tap water implemented villages of previous arseniasis-hyperendemic regions in Taiwan were prospectively followed for an average of 8 years. For each resident, a 12-lead conventional electrocardiogram (ECG) was recorded and coded by Minnesota Code standard criteria. Eight functional polymorphisms of PON1, PON2, AS3MT, GSTO1, and GSTO2 were examined for genetic susceptibility to ECG abnormality. Among 42 incident cases with ECG deterioration identified among 121 baseline-normal subjects, arsenic exposure was significantly correlated with incidence of ECG abnormality. In addition, polymorphisms in two paraoxonase genes were also found associated with the incidence of ECG abnormality. A haplotype R-C-S constituted by polymorphisms of PON1 Q192R, -108C/T and PON2 C311S was linked to the increased risk. Subjects exposed to high levels of As (cumulative As exposure >14.7 ppm-year or drinking artesian well water >21 years) and carrying the R-C-S haplotype had significantly increased risks for ECG abnormality over those with only one risk factor. Results of this study showed a long-term arsenic effect on ECG abnormality and significant gene-gene and gene-environment interactions linked to the incidence of CVD. This finding might have important implications for a novel and potentially useful biomarker of arsenic risk.Arsenic has been linked to increased prevalence of cancer and cardiovascular disease (CVD), but the long-term impact of arsenic exposure remains unclear. Human paraoxonase (PON1) is a high-density lipoprotein-associated antioxidant enzyme which hydrolyzes oxidized lipids and is thought to be protective against atherosclerosis, but evidence remains limited to case-control studies. Only recently have genes encoding enzymes responsible for arsenic metabolism, such as AS3MT and GSTO, been cloned and characterized. This study was designed to evaluate the synergistic interaction of genetic factors and arsenic exposure on electrocardiogram abnormality. A total of 216 residents from three tap water implemented villages of previous arseniasis-hyperendemic regions in Taiwan were prospectively followed for an average of 8 years. For each resident, a 12-lead conventional electrocardiogram (ECG) was recorded and coded by Minnesota Code standard criteria. Eight functional polymorphisms of PON1, PON2, AS3MT, GSTO1, and GSTO2 were examined for genetic susceptibility to ECG abnormality. Among 42 incident cases with ECG deterioration identified among 121 baseline-normal subjects, arsenic exposure was significantly correlated with incidence of ECG abnormality. In addition, polymorphisms in two paraoxonase genes were also found associated with the incidence of ECG abnormality. A haplotype R-C-S constituted by polymorphisms of PON1 Q192R, -108C/T and PON2 C311S was linked to the increased risk. Subjects exposed to high levels of As (cumulative As exposure >14.7 ppm-year or drinking artesian well water >21 years) and carrying the R-C-S haplotype had significantly increased risks for ECG abnormality over those with only one risk factor. Results of this study showed a long-term arsenic effect on ECG abnormality and significant gene-gene and gene-environment interactions linked to the incidence of CVD. This finding might have important implications for a novel and potentially useful biomarker of arsenic risk. |
Author | Prineas, Ronald J. Liao, Ya-Tang Li, Wan-Fen Chen, Wei J. Chen, Chien-Jen Zhang, Zhu-Ming Sun, Chien-Wen Wang, Shu-Li |
Author_xml | – sequence: 1 givenname: Ya-Tang surname: Liao fullname: Liao, Ya-Tang organization: Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Taiwan – sequence: 2 givenname: Wan-Fen surname: Li fullname: Li, Wan-Fen organization: Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Taiwan – sequence: 3 givenname: Chien-Jen surname: Chen fullname: Chen, Chien-Jen organization: Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taiwan – sequence: 4 givenname: Ronald J. surname: Prineas fullname: Prineas, Ronald J. organization: Epidemiologic Cardiology Research Center, Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine, NC, USA – sequence: 5 givenname: Wei J. surname: Chen fullname: Chen, Wei J. organization: Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taiwan – sequence: 6 givenname: Zhu-Ming surname: Zhang fullname: Zhang, Zhu-Ming organization: Epidemiologic Cardiology Research Center, Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine, NC, USA – sequence: 7 givenname: Chien-Wen surname: Sun fullname: Sun, Chien-Wen organization: Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Taiwan – sequence: 8 givenname: Shu-Li surname: Wang fullname: Wang, Shu-Li email: slwang@nhri.org.tw organization: Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Taiwan |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22014850$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19152805$$D View this record in MEDLINE/PubMed https://www.osti.gov/biblio/21272641$$D View this record in Osti.gov |
BookMark | eNqFkj1vFDEQhi0URC6BP0CBVkKku8Pj_bREgyICSJEoSEFnzdnji0-79mLvoty_x8sdKShCZcl-ntHM-L1gZz54Yuw18A1waN7vNxPiuBGcdxsQGw7tM7YCLps1L8vyjK04r2CdX3-cs4uU9pxzWVXwgp2DhFp0vF6x-fvBU9y5NDldkLWkpyLYYgz9YQhxvHdpSH8uMGJ4CB4TFTvyVOh-ThPFAr0pMCbyi_8whjRHKoIvqM-lYtAYjQu7iEOBWx_igL2bDi_Zc4t9olen85Ld3Xy6u_6yvv32-ev1x9u1rrmc1nUDKFtsSkENt12tZdsJNJ0wlQBpGwOmNlZKIostaiq3aKQQorR1CyWUl-ztsWzI46mk3UT6Xgfvc2tKgGhFUy3U1ZEaY_g5U5rU4JKmvkdPYU6qaRsoG9n9FxS85VDWVQbfnMB5O5BRY3QDxoP6u_YMvDsBmDT2NqLXLj1yQnCouppnrjtyOoaUIlmVZ8DJBT9FdL0CrpYkqL1akqCWJCgQKichq-If9bGLp6QPR4nyp_xyFJelkddkXFx2ZoJ7Sv8ND3bOEA |
CODEN | TXAPA9 |
CitedBy_id | crossref_primary_10_1016_j_taap_2009_12_031 crossref_primary_10_1016_j_gene_2012_06_031 crossref_primary_10_1007_s00204_016_1691_1 crossref_primary_10_1016_j_fct_2013_03_048 crossref_primary_10_1093_ije_dyr022 crossref_primary_10_3109_13880209_2015_1043562 crossref_primary_10_2486_indhealth_47_455 crossref_primary_10_1007_s11883_012_0280_x crossref_primary_10_1016_j_envres_2012_04_016 crossref_primary_10_2903_j_efsa_2009_1351 crossref_primary_10_1016_j_jtcme_2017_05_003 |
Cites_doi | 10.1161/01.HYP.25.1.53 10.1001/jama.299.11.1265 10.1289/ehp.02110729 10.1016/S0378-4274(99)00271-4 10.1517/14622416.3.3.341 10.1016/j.taap.2006.12.022 10.1002/sim.1931 10.1074/jbc.M110246200 10.1172/JCI118359 10.1016/S0140-6736(04)15642-0 10.1289/ehp.011091265 10.1016/S0006-291X(02)03066-8 10.1126/science.1072896 10.1161/01.CIR.101.21.2510 10.1093/aje/kwi330 10.2165/00129785-200303030-00002 10.1038/28406 10.1016/S0090-9556(24)15082-9 10.1177/000331978904000606 10.1016/S0013-9351(02)00081-6 10.1016/0014-5793(91)80962-3 10.1161/01.ATV.20.11.2441 10.1016/S0378-4274(02)00377-6 10.1172/JCI1649 10.1161/01.CIR.0000070954.00271.13 |
ContentType | Journal Article Conference Proceeding |
Copyright | 2008 Elsevier Inc. 2009 INIST-CNRS |
Copyright_xml | – notice: 2008 Elsevier Inc. – notice: 2009 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7ST 7TV 7U7 8FD C1K FR3 P64 RC3 SOI 7X8 OTOTI |
DOI | 10.1016/j.taap.2008.12.017 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Environment Abstracts Pollution Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts Environment Abstracts MEDLINE - Academic OSTI.GOV |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Technology Research Database Toxicology Abstracts Engineering Research Database Pollution Abstracts Environment Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1096-0333 |
EndPage | 183 |
ExternalDocumentID | 21272641 19152805 22014850 10_1016_j_taap_2008_12_017 S0041008X08005255 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Taiwan USA, Minnesota |
GeographicLocations_xml | – name: Taiwan – name: USA, Minnesota |
GroupedDBID | --- --K --M .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKC AAIKJ AAKOC AALRI AAMNW AAOAW AAQFI AATCM AAXUO ABFRF ABFYP ABJNI ABLST ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHEUO AIEXJ AIKHN AITUG AJBFU AJOXV AKIFW ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLECG BLXMC C45 CS3 DM4 EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q HZ~ IHE J1W KCYFY KOM LG5 M33 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SDP SES SPCBC SSJ SSP SSZ T5K TEORI TWZ WH7 ZU3 ~G- .55 .GJ .HR 29Q 3O- 53G AAQXK AATTM AAXKI AAYWO AAYXX ABEFU ABFNM ABWVN ACLOT ACRPL ACVFH ADCNI ADFGL ADNMO AEIPS AEUPX AFJKZ AFPUW AGQPQ AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN CAG CITATION COF EFKBS FEDTE FGOYB G-2 GBLVA HMT HVGLF P-8 R2- SEW SPT UHS WUQ X7M XJT XPP Y6R ZGI ZKB ZMT ZXP ~HD ~KM BNPGV IQODW SSH YCJ CGR CUY CVF ECM EIF NPM 7ST 7TV 7U7 8FD C1K FR3 P64 RC3 SOI 7X8 AALMO AAPBV ABPIF ABPTK ABQIS EFJIC OTOTI |
ID | FETCH-LOGICAL-c509t-561a97a632e60f85c9782ad82d4219f6d1d5df99eefa7ace3bad92223f571313 |
IEDL.DBID | .~1 |
ISSN | 0041-008X 1096-0333 |
IngestDate | Thu May 18 18:35:57 EDT 2023 Wed Oct 01 08:26:10 EDT 2025 Sat Sep 27 23:38:40 EDT 2025 Thu Apr 03 07:07:03 EDT 2025 Wed Apr 02 07:23:29 EDT 2025 Wed Oct 01 05:12:32 EDT 2025 Thu Apr 24 22:59:33 EDT 2025 Fri Feb 23 02:28:19 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Ischemic heart disease Drinking water Arsenic Electrocardiogram Arsenic methyltransferase Paraoxonase Glutathione S-transferases omega Genetic variability Toxicity Cardiovascular disease Myocardial ischemia Esterases Myocardial disease Vascular disease Phosphoric triester hydrolases Glutathione transferase Electrocardiography Aryldialkylphosphatase Gene cluster Enzyme Transferases Genotype Exposure Coronary heart disease Carcinogen Methyltransferases Hydrolases Polymorphism |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MeetingName | Arsenic from Nature to Humans. Articles from the Valencia, Spain Arsenic Meeting of May 21-23, 2008 |
MergedId | FETCHMERGED-LOGICAL-c509t-561a97a632e60f85c9782ad82d4219f6d1d5df99eefa7ace3bad92223f571313 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 19152805 |
PQID | 20701354 |
PQPubID | 23462 |
PageCount | 6 |
ParticipantIDs | osti_scitechconnect_21272641 proquest_miscellaneous_67613698 proquest_miscellaneous_20701354 pubmed_primary_19152805 pascalfrancis_primary_22014850 crossref_citationtrail_10_1016_j_taap_2008_12_017 crossref_primary_10_1016_j_taap_2008_12_017 elsevier_sciencedirect_doi_10_1016_j_taap_2008_12_017 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-09-01 |
PublicationDateYYYYMMDD | 2009-09-01 |
PublicationDate_xml | – month: 09 year: 2009 text: 2009-09-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: United States |
PublicationTitle | Toxicology and applied pharmacology |
PublicationTitleAlternate | Toxicol Appl Pharmacol |
PublicationYear | 2009 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Lin, Shi, Nix, Styblo, Beck, Herbin-Davis, Hall, Simeonsson, Thomas (bib17) 2002; 277 Chen, Chuang, Lin, Wu (bib9) 1985; 45 Chen, Chen (bib6) 1975 World Medical Association (2000). Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. In Bulletin of Medical Ethics pp. 8–11. Vahter, M. (2000). Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett 112–113, 209–217. Wang, Hsiao, Chen, Hsu, Chiou, Chen, Hsueh, Wu, Chen (bib32) 2007; 222 Watanabe, Inaoka, Kadono, Nagano, Nakamura, Ushijima, Murayama, Miyazaki, Ohtsuka (bib33) 2001; 109 Wheeler, Keavney, Watkins, Collins, Danesh (bib35) 2004; 363 Chung, Kalman, Moore, Kosnett, Arroyo, Beeris, Mazumder, Hernandez, Smith (bib12) 2002; 110 Tanaka-Kagawa, Jinno, Hasegawa, Makino, Seko, Hanioka, Ando (bib27) 2003; 301 Tseng, Chong, Tseng, Hsueh, Chiou, Tseng, Chen (bib30) 2003; 137 (bib22) 1999 Blackwell (bib5) 1961; 60 Chen, Lin (bib7) 1994 Potter (bib23) 2005; 24 Navas-Acien, Sharrett, Silbergeld, Schwartz, Nachman, Burke, Guallar (bib21) 2005; 162 Loffredo, Aposhian, Cebrian, Yamauchi, Silbergeld (bib18) 2003; 92 Prineas, R. J., Crow, R. S., and Blackburn, H. (1982). The Minnesota Code Manual of Electrocardiographic Findings. (John Wright PSB Inc., Ed.). MA, Boston. Chen, Hsueh, Lai, Shyu, Chen, Wu, Kuo, Tai (bib10) 1995; 25 Townsend, Tew (bib28) 2003; 3 Tseng (bib29) 1989; 40 Wu, Chen, Tseng, Hsu (bib37) 1961; 7 Department of Health, Executive Yuan (Taiwan) R. O. C. (2005). Health and Vital statistics—Vital Statistics. Mackness, Arrol, Durrington (bib19) 1991; 286 Chen, Wu, Wu (bib8) 1962; 8 Mackness, Durrington, McElduff, Yarnell, Azam, Watt, Mackness (bib20) 2003; 107 Billecke, Draganov, Counsell, Stetson, Watson, Hsu, La Du (bib4) 2000; 28 Watson, Berliner, Hama, La Du, Faull, Fogelman, Navab (bib34) 1995; 96 Jarvik, Rozek, Brophy, Hatsukami, Richter, Schellenberg, Furlong (bib15) 2000; 20 Aviram, Hardak, Vaya, Mahmood, Milo, Hoffman, Billicke, Draganov, Rosenblat (bib2) 2000; 101 Shih, Gu, Xia, Navab, Li, Hama, Castellani, Furlong, Costa, Fogelman, Lusis (bib25) 1998; 394 Smith, Lopipero, Bates, Steinmaus (bib26) 2002; 296 Aviram, Rosenblat, Bisgaier, Newton, Primo-Parmo, La Du (bib1) 1998; 101 Furlong, Cole, Jarvik, Costa (bib14) 2002; 3 Kuo, T. L. (1964). Arsenic Content of Artesian Well Water in Endemic Area of Chronic Arsenic Poisoning In Institute of Pathology, pp. 7–13. National Taiwan University. Bhattacharyya, Nicholls, Topol, Zhang, Yang, Schmitt, Fu, Shao, Brennan, Ellis, Brennan, Allayee, Lusis, Hazen (bib3) 2008; 299 Chung (10.1016/j.taap.2008.12.017_bib12) 2002; 110 10.1016/j.taap.2008.12.017_bib24 Chen (10.1016/j.taap.2008.12.017_bib10) 1995; 25 Billecke (10.1016/j.taap.2008.12.017_bib4) 2000; 28 Watson (10.1016/j.taap.2008.12.017_bib34) 1995; 96 Smith (10.1016/j.taap.2008.12.017_bib26) 2002; 296 Mackness (10.1016/j.taap.2008.12.017_bib20) 2003; 107 Wheeler (10.1016/j.taap.2008.12.017_bib35) 2004; 363 Blackwell (10.1016/j.taap.2008.12.017_bib5) 1961; 60 Potter (10.1016/j.taap.2008.12.017_bib23) 2005; 24 Tanaka-Kagawa (10.1016/j.taap.2008.12.017_bib27) 2003; 301 Navas-Acien (10.1016/j.taap.2008.12.017_bib21) 2005; 162 (10.1016/j.taap.2008.12.017_bib22) 1999 Chen (10.1016/j.taap.2008.12.017_bib9) 1985; 45 Tseng (10.1016/j.taap.2008.12.017_bib29) 1989; 40 Chen (10.1016/j.taap.2008.12.017_bib7) 1994 Wang (10.1016/j.taap.2008.12.017_bib32) 2007; 222 Wu (10.1016/j.taap.2008.12.017_bib37) 1961; 7 Watanabe (10.1016/j.taap.2008.12.017_bib33) 2001; 109 Bhattacharyya (10.1016/j.taap.2008.12.017_bib3) 2008; 299 Jarvik (10.1016/j.taap.2008.12.017_bib15) 2000; 20 10.1016/j.taap.2008.12.017_bib16 10.1016/j.taap.2008.12.017_bib36 Chen (10.1016/j.taap.2008.12.017_bib8) 1962; 8 Aviram (10.1016/j.taap.2008.12.017_bib2) 2000; 101 Lin (10.1016/j.taap.2008.12.017_bib17) 2002; 277 Shih (10.1016/j.taap.2008.12.017_bib25) 1998; 394 10.1016/j.taap.2008.12.017_bib13 10.1016/j.taap.2008.12.017_bib31 Loffredo (10.1016/j.taap.2008.12.017_bib18) 2003; 92 Mackness (10.1016/j.taap.2008.12.017_bib19) 1991; 286 Aviram (10.1016/j.taap.2008.12.017_bib1) 1998; 101 Chen (10.1016/j.taap.2008.12.017_bib6) 1975 Furlong (10.1016/j.taap.2008.12.017_bib14) 2002; 3 Townsend (10.1016/j.taap.2008.12.017_bib28) 2003; 3 Tseng (10.1016/j.taap.2008.12.017_bib30) 2003; 137 |
References_xml | – volume: 92 start-page: 85 year: 2003 end-page: 91 ident: bib18 article-title: Variability in human metabolism of arsenic publication-title: Environ. Res. – volume: 137 start-page: 15 year: 2003 end-page: 21 ident: bib30 article-title: Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan publication-title: Toxicol. Lett. – volume: 7 start-page: 1 year: 1961 end-page: 18 ident: bib37 article-title: Epidemiologic studies on blackfoot disease: prevalence and incidence of the disease by age, sex, year, occupation, and geographic distribution publication-title: Memoirs of College of Medicine (National Taiwan University) – reference: Prineas, R. J., Crow, R. S., and Blackburn, H. (1982). The Minnesota Code Manual of Electrocardiographic Findings. (John Wright PSB Inc., Ed.). MA, Boston. – volume: 3 start-page: 341 year: 2002 end-page: 348 ident: bib14 article-title: Pharmacogenomic considerations of the paraoxonase polymorphisms publication-title: Pharmacogenomics – volume: 28 start-page: 1335 year: 2000 end-page: 1342 ident: bib4 article-title: Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters publication-title: Drug Metab. Dispos. – reference: World Medical Association (2000). Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. In Bulletin of Medical Ethics pp. 8–11. – year: 1994 ident: bib7 article-title: Human carcinogenicity and atherogenicity induced by chronic exposure to inorganic arsenic publication-title: Progress in Arsenic in the Environment, Part II – volume: 60 start-page: 1143 year: 1961 end-page: 1144 ident: bib5 article-title: Estimation total arsenic ingested by residents in the endemic blackfoot area publication-title: J. Formosan. Med. Assoc. – volume: 286 start-page: 152 year: 1991 end-page: 154 ident: bib19 article-title: Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein publication-title: FEBS Lett. – volume: 40 start-page: 547 year: 1989 end-page: 558 ident: bib29 article-title: Blackfoot disease in Taiwan: a 30-year follow-up study publication-title: Angiology – volume: 296 start-page: 2145 year: 2002 end-page: 2146 ident: bib26 article-title: Public health. Arsenic epidemiology and drinking water standards publication-title: Science – reference: Vahter, M. (2000). Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett 112–113, 209–217. – volume: 301 start-page: 516 year: 2003 end-page: 520 ident: bib27 article-title: Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn) publication-title: Biochem. Biophys. Res. Commun. – volume: 45 start-page: 5895 year: 1985 end-page: 5899 ident: bib9 article-title: Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers publication-title: Cancer Res. – volume: 277 start-page: 10795 year: 2002 end-page: 10803 ident: bib17 article-title: A novel S-adenosyl- publication-title: J. Biol. Chem. – volume: 110 start-page: 729 year: 2002 end-page: 733 ident: bib12 article-title: Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water publication-title: Environ. Health Perspect. – volume: 25 start-page: 53 year: 1995 end-page: 60 ident: bib10 article-title: Increased prevalence of hypertension and long-term arsenic exposure publication-title: Hypertension – volume: 299 start-page: 1265 year: 2008 end-page: 1276 ident: bib3 article-title: Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk publication-title: JAMA – reference: Department of Health, Executive Yuan (Taiwan) R. O. C. (2005). Health and Vital statistics—Vital Statistics. – reference: Kuo, T. L. (1964). Arsenic Content of Artesian Well Water in Endemic Area of Chronic Arsenic Poisoning In Institute of Pathology, pp. 7–13. National Taiwan University. – volume: 162 start-page: 1037 year: 2005 end-page: 1049 ident: bib21 article-title: Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence publication-title: Am. J. Epidemiol. – volume: 101 start-page: 2510 year: 2000 end-page: 2517 ident: bib2 article-title: Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities publication-title: Circulation – year: 1999 ident: bib22 publication-title: Arsenic in Drinking Water – volume: 8 start-page: 115 year: 1962 end-page: 129 ident: bib8 article-title: Epidemiologic studies on blackfoot disease in Taiwan. 3. Physicochemical characteristics of drinking water in endemic blackfoot disease areas publication-title: Memoirs of College of Medicine (National Taiwan University) – volume: 394 start-page: 284 year: 1998 end-page: 287 ident: bib25 article-title: Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis publication-title: Nature – volume: 107 start-page: 2775 year: 2003 end-page: 2779 ident: bib20 article-title: Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study publication-title: Circulation – volume: 3 start-page: 157 year: 2003 end-page: 172 ident: bib28 article-title: Cancer drugs, genetic variation and the glutathione-S-transferase gene family publication-title: Am. J. Pharmacogenomics – volume: 24 start-page: 693 year: 2005 end-page: 708 ident: bib23 article-title: A permutation test for inference in logistic regression with small- and moderate-sized data sets publication-title: Stat. Med. – volume: 20 start-page: 2441 year: 2000 end-page: 2447 ident: bib15 article-title: Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype publication-title: Arterioscler. Thromb. Vasc. Biol. – volume: 363 start-page: 689 year: 2004 end-page: 695 ident: bib35 article-title: Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies publication-title: Lancet – volume: 101 start-page: 1581 year: 1998 end-page: 1590 ident: bib1 article-title: Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase publication-title: J. Clin. Invest. – volume: 109 start-page: 1265 year: 2001 end-page: 1270 ident: bib33 article-title: Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: analyses based on urinary arsenic publication-title: Environ. Health Perspect. – volume: 222 start-page: 315 year: 2007 end-page: 326 ident: bib32 article-title: A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases publication-title: Toxicol. Appl. Pharmacol. – volume: 96 start-page: 2882 year: 1995 end-page: 2891 ident: bib34 article-title: Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein publication-title: J. Clin. Invest. – year: 1975 ident: bib6 article-title: Study on arsenic artesian well water and blackfoot disease progress publication-title: In Taichung, Taiwan: Taiwan Provincial Institute of Environmental Sanitation – volume: 25 start-page: 53 year: 1995 ident: 10.1016/j.taap.2008.12.017_bib10 article-title: Increased prevalence of hypertension and long-term arsenic exposure publication-title: Hypertension doi: 10.1161/01.HYP.25.1.53 – year: 1975 ident: 10.1016/j.taap.2008.12.017_bib6 article-title: Study on arsenic artesian well water and blackfoot disease progress – volume: 299 start-page: 1265 year: 2008 ident: 10.1016/j.taap.2008.12.017_bib3 article-title: Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk publication-title: JAMA doi: 10.1001/jama.299.11.1265 – volume: 110 start-page: 729 year: 2002 ident: 10.1016/j.taap.2008.12.017_bib12 article-title: Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water publication-title: Environ. Health Perspect. doi: 10.1289/ehp.02110729 – ident: 10.1016/j.taap.2008.12.017_bib31 doi: 10.1016/S0378-4274(99)00271-4 – volume: 3 start-page: 341 year: 2002 ident: 10.1016/j.taap.2008.12.017_bib14 article-title: Pharmacogenomic considerations of the paraoxonase polymorphisms publication-title: Pharmacogenomics doi: 10.1517/14622416.3.3.341 – ident: 10.1016/j.taap.2008.12.017_bib24 – year: 1994 ident: 10.1016/j.taap.2008.12.017_bib7 article-title: Human carcinogenicity and atherogenicity induced by chronic exposure to inorganic arsenic – volume: 222 start-page: 315 year: 2007 ident: 10.1016/j.taap.2008.12.017_bib32 article-title: A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/j.taap.2006.12.022 – volume: 24 start-page: 693 year: 2005 ident: 10.1016/j.taap.2008.12.017_bib23 article-title: A permutation test for inference in logistic regression with small- and moderate-sized data sets publication-title: Stat. Med. doi: 10.1002/sim.1931 – volume: 277 start-page: 10795 year: 2002 ident: 10.1016/j.taap.2008.12.017_bib17 article-title: A novel S-adenosyl-l-methionine:arsenic(III) methyltransferase from rat liver cytosol publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110246200 – volume: 8 start-page: 115 year: 1962 ident: 10.1016/j.taap.2008.12.017_bib8 article-title: Epidemiologic studies on blackfoot disease in Taiwan. 3. Physicochemical characteristics of drinking water in endemic blackfoot disease areas publication-title: Memoirs of College of Medicine (National Taiwan University) – ident: 10.1016/j.taap.2008.12.017_bib16 – volume: 96 start-page: 2882 year: 1995 ident: 10.1016/j.taap.2008.12.017_bib34 article-title: Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein publication-title: J. Clin. Invest. doi: 10.1172/JCI118359 – volume: 363 start-page: 689 year: 2004 ident: 10.1016/j.taap.2008.12.017_bib35 article-title: Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies publication-title: Lancet doi: 10.1016/S0140-6736(04)15642-0 – volume: 109 start-page: 1265 year: 2001 ident: 10.1016/j.taap.2008.12.017_bib33 article-title: Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: analyses based on urinary arsenic publication-title: Environ. Health Perspect. doi: 10.1289/ehp.011091265 – volume: 60 start-page: 1143 year: 1961 ident: 10.1016/j.taap.2008.12.017_bib5 article-title: Estimation total arsenic ingested by residents in the endemic blackfoot area publication-title: J. Formosan. Med. Assoc. – ident: 10.1016/j.taap.2008.12.017_bib36 – volume: 301 start-page: 516 year: 2003 ident: 10.1016/j.taap.2008.12.017_bib27 article-title: Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn) publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/S0006-291X(02)03066-8 – year: 1999 ident: 10.1016/j.taap.2008.12.017_bib22 – volume: 296 start-page: 2145 year: 2002 ident: 10.1016/j.taap.2008.12.017_bib26 article-title: Public health. Arsenic epidemiology and drinking water standards publication-title: Science doi: 10.1126/science.1072896 – volume: 101 start-page: 2510 year: 2000 ident: 10.1016/j.taap.2008.12.017_bib2 article-title: Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities publication-title: Circulation doi: 10.1161/01.CIR.101.21.2510 – volume: 45 start-page: 5895 year: 1985 ident: 10.1016/j.taap.2008.12.017_bib9 article-title: Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers publication-title: Cancer Res. – volume: 162 start-page: 1037 year: 2005 ident: 10.1016/j.taap.2008.12.017_bib21 article-title: Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence publication-title: Am. J. Epidemiol. doi: 10.1093/aje/kwi330 – volume: 3 start-page: 157 year: 2003 ident: 10.1016/j.taap.2008.12.017_bib28 article-title: Cancer drugs, genetic variation and the glutathione-S-transferase gene family publication-title: Am. J. Pharmacogenomics doi: 10.2165/00129785-200303030-00002 – volume: 394 start-page: 284 year: 1998 ident: 10.1016/j.taap.2008.12.017_bib25 article-title: Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis publication-title: Nature doi: 10.1038/28406 – volume: 28 start-page: 1335 year: 2000 ident: 10.1016/j.taap.2008.12.017_bib4 article-title: Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters publication-title: Drug Metab. Dispos. doi: 10.1016/S0090-9556(24)15082-9 – volume: 40 start-page: 547 year: 1989 ident: 10.1016/j.taap.2008.12.017_bib29 article-title: Blackfoot disease in Taiwan: a 30-year follow-up study publication-title: Angiology doi: 10.1177/000331978904000606 – volume: 7 start-page: 1 year: 1961 ident: 10.1016/j.taap.2008.12.017_bib37 article-title: Epidemiologic studies on blackfoot disease: prevalence and incidence of the disease by age, sex, year, occupation, and geographic distribution publication-title: Memoirs of College of Medicine (National Taiwan University) – volume: 92 start-page: 85 year: 2003 ident: 10.1016/j.taap.2008.12.017_bib18 article-title: Variability in human metabolism of arsenic publication-title: Environ. Res. doi: 10.1016/S0013-9351(02)00081-6 – volume: 286 start-page: 152 year: 1991 ident: 10.1016/j.taap.2008.12.017_bib19 article-title: Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein publication-title: FEBS Lett. doi: 10.1016/0014-5793(91)80962-3 – volume: 20 start-page: 2441 year: 2000 ident: 10.1016/j.taap.2008.12.017_bib15 article-title: Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.20.11.2441 – volume: 137 start-page: 15 year: 2003 ident: 10.1016/j.taap.2008.12.017_bib30 article-title: Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan publication-title: Toxicol. Lett. doi: 10.1016/S0378-4274(02)00377-6 – volume: 101 start-page: 1581 year: 1998 ident: 10.1016/j.taap.2008.12.017_bib1 article-title: Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase publication-title: J. Clin. Invest. doi: 10.1172/JCI1649 – ident: 10.1016/j.taap.2008.12.017_bib13 – volume: 107 start-page: 2775 year: 2003 ident: 10.1016/j.taap.2008.12.017_bib20 article-title: Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study publication-title: Circulation doi: 10.1161/01.CIR.0000070954.00271.13 |
SSID | ssj0009441 |
Score | 2.018719 |
Snippet | Arsenic has been linked to increased prevalence of cancer and cardiovascular disease (CVD), but the long-term impact of arsenic exposure remains unclear. Human... |
SourceID | osti proquest pubmed pascalfrancis crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 178 |
SubjectTerms | 60 APPLIED LIFE SCIENCES ARSENIC Arsenic methyltransferase Arsenic Poisoning - complications Arsenic Poisoning - epidemiology ARTERIOSCLEROSIS Aryldialkylphosphatase - genetics Biological and medical sciences Carcinogenesis, carcinogens and anticarcinogens Cardiology. Vascular system Cardiovascular Diseases - enzymology Cardiovascular Diseases - epidemiology Cardiovascular Diseases - etiology Cardiovascular Diseases - genetics Chemical agents Chemical and industrial products toxicology. Toxic occupational diseases Coronary heart disease DRINKING WATER Electrocardiogram ELECTROCARDIOGRAMS Electrocardiography Environmental Exposure - adverse effects Female GENES GLUTATHIONE Glutathione S-transferases omega Haplotypes HAZARDS Heart HUMAN POPULATIONS Humans Incidence Ischemic heart disease LIPOPROTEINS Male Medical sciences METABOLISM Metals and various inorganic compounds Middle Aged Multigene Family Myocarditis. Cardiomyopathies NEOPLASMS Paraoxonase Polymorphism, Single Nucleotide Prospective Studies Taiwan - epidemiology Toxicology TRANSFERASES Tumors Water Pollutants, Chemical - toxicity |
Title | Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality |
URI | https://dx.doi.org/10.1016/j.taap.2008.12.017 https://www.ncbi.nlm.nih.gov/pubmed/19152805 https://www.proquest.com/docview/20701354 https://www.proquest.com/docview/67613698 https://www.osti.gov/biblio/21272641 |
Volume | 239 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier Complete Freedom Collection customDbUrl: eissn: 1096-0333 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009441 issn: 0041-008X databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1096-0333 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009441 issn: 0041-008X databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1096-0333 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009441 issn: 0041-008X databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1096-0333 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009441 issn: 0041-008X databaseCode: AKRWK dateStart: 19930101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7C9lIopU1fbtOtDiWXxs3aK9nWMYSGbUtDoFvYm5H1gC0by8S7kL3kt2fGsrMEmhx6FRpseUajb-RvZgA-Oyd1YrNJXOFGinnKdaw0AjleSTxutKhkQbnDv86z2R_-YyEWe3A65MIQrbL3_cGnd966Hznuv-Zxs1xSji-nyjQLwjwCkTFlsPOMaH1fb3Y0D8l56JrHMWzG2X3iTOB4rZVqAp-SrgS7pmX_PJxGHvcb0SZVi1_OhZYXD2PS7mw6ewHPe1DJTsJ7v4Q9W-_D4UWoSr09YvNdklV7xA7Zxa5e9XYfnoWrOxYykl7B5veWEgK7Cs4s8D2Yd6zxq-2lR7Us28u2G1BXyl8jkm8tQzO0TK82VHaBqdowjJdtTfLXjadLSOZr1rfc0R0FllhhTFU1YWYKBV7D_Ozb_HQW990ZYo0gYx0j8FIyV9k0RVW7QmiMR1NlitRw9IIuM4kRxklprVO50nZaKSMJjTiBgXEyfQOj2tf2HbAMnYwpCovIynCO04VW06KyKq8m3CQugmTQSqn7yuXUQGNVDhS1vyVpMrTUTNISNRnBlzuZJtTteHS2GJRd3rO-Eg-WR-UOyDJIhkruauImoRBVzUegmUQwvmcxd2-SpnSRKyYRfBpMqMRtTf9qVG39psWH5AjOBX94RpYjEstkEcHbYHu7dUoEZcVEvP_PVX2Ap-GfGTHpDmC0vtrYjwi91tW421tjeHLy_efs_Bbg2TAz |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB7RcGilCrX0ZUphDxWXYhE7u34cESoKBSKkplJu1nofUlCwLZxI5N93xrsmQiocerV25MfMzn67_uYbgO_W5ioyyTAscSKFPOYqlAqBHC9zXG6UKPOMaoevJ8n4D_81E7MtOOtrYYhW6XO_y-ldtvZXTvzXPGnmc6rx5aRMMyPMIxAZv4JtLjAnD2D79OJyPNlo73LuGudx3Dmjga-dcTSvpZSNo1TSqWDXt-yf69OgxilHzEnZ4sezruvF87C0W57O38GOx5Xs1D36e9gy1S4c3Thh6vUxm27qrNpjdsRuNpLV6114607vmCtK-gCr32uqCexEnJmjfLDasqZerO9q9My8vWu7C_Je1g8I5lvDMBINU4sVKS8wWWmGW2ZTkf1DU9M5JKsr5rvuqI4FS8QwJsuKYDPtBj7C9Pzn9Gwc-gYNoUKcsQwRe8k8lckoRm_bTCjcksZSZ7HmmAhtoiMttM1zY6xMpTKjUuqcAIkVuDeORp9gUNWV-QIswTyjs8wguNKc43Ch5CgrjUzLIdeRDSDqvVIoL15OPTQWRc9Suy3Ik66rZhQX6MkAfjzaNE6648XRond28SQAC1xbXrTbp8ggG1LdVURPQiMSzkesGQVw8CRiHp8kjuksVwwDOOxDqMCZTb9rZGXqVYs3SRGfC_78iCRFMJbkWQCfXext3jNHXJYNxd5_vtUhvB5Pr6-Kq4vJ5Vd4436hEbFuHwbL-5X5hkhsWR74mfYXFz4y3g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Toxicology+and+applied+pharmacology&rft.atitle=Synergistic+effect+of+polymorphisms+of+paraoxonase+gene+cluster+and+arsenic+exposure+on+electrocardiogram+abnormality&rft.au=LIAO%2C+Ya-Tang&rft.au=LI%2C+Wan-Fen&rft.au=CHEN%2C+Chien-Jen&rft.au=PRINEAS%2C+Ronald+J&rft.date=2009-09-01&rft.pub=Elsevier&rft.issn=0041-008X&rft.volume=239&rft.issue=2&rft.spage=178&rft.epage=183&rft_id=info:doi/10.1016%2Fj.taap.2008.12.017&rft.externalDBID=n%2Fa&rft.externalDocID=22014850 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0041-008X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0041-008X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0041-008X&client=summon |